Comparison of genomic signatures of non-small cell lung cancer recurrence between two microarray platforms

Anticancer Research

Volumn 32, Issue 4, 2012, Pages 1259-1265

  Chang, John Wen Cheng ^a   Wei, Nien Chih ^b   Su, Hung Ju ^c   Huang, Jie Len ^c   Chen, Tse Ching ^a   Wu, Yi Cheng ^a   Yu, Chih Teng ^a   Hou, Ming Mo ^a   Hsieh, Chia Hsun ^a   Hsieh, Jia Juan ^a,d   Wu, Chiao En ^a   Cheng, Hsin Yi ^a   Hsu, Todd ^d   Wang, Tzu Hao ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b Auspex Diagnostics ^*  (Taiwan)

^c INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE   (Taiwan)

^d NATIONAL TAIWAN OCEAN UNIVERSITY   (Taiwan)

Author keywords

FJX1; Genomic signature; LCN2; Lung cancer; Microarray; NSCLC; PTHLH; RAB38; Tumor recurrence

Indexed keywords

NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PARATHYROID HORMONE; RAP PROTEIN; RNA;

ARTICLE; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; UNIVARIATE ANALYSIS; VALIDATION PROCESS;

CARCINOMA, NON-SMALL-CELL LUNG; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; LUNG NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECURRENCE; SURVIVAL RATE;

EID: 84859992579     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Silvestri GA and Rivera MP: Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists. Chest 128: 3975-3984, 2005. (Pubitemid 43062660)
2. Drmanac S and Drmanac R: Processing of cDNA and genomic kilobase-size clones for massive screening, mapping and sequencing by hybridization. Biotechniques 17: 328-329 and 332-336, 1994.
3. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H and Brown EL: Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14: 1675-1680, 1996. (Pubitemid 26414810)
4. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J and Wolmark N: A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351: 2817-2826, 2004. (Pubitemid 40051905)
5. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R and Friend SH: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536, 2002. (Pubitemid 34130608)
6. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH and Bernards R: A gene expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009, 2002. (Pubitemid 35461656)
7. Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, Yuan A, Cheng CL, Wang CH, Terng HJ, Kao SF, Chan WK, Li HN, Liu CC, Singh S, Chen WJ, Chen JJW and Yang PC: A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 356: 11-20, 2007. (Pubitemid 46041749)
8. URL: http://www.affymetrix.com/support/technical/datasheets/human- datasheet.pdf
9. Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, Baker SC, Collins PJ, de Longueville F, Kawasaki ES, Lee KY, Luo Y, Sun YA, Willey JC, Setterquist RA, Fischer GM, Tong W, Dragan YP, Dix DJ, Frueh FW, Goodsaid FM, Herman D, Jensen RV, Johnson CD, Lobenhofer EK, Puri RK, Schrf U, Thierry-Mieg J, Wang C, Wilson M, Wolber PK, Zhang L, Amur S, Bao W, Barbacioru CC, Lucas AB, Bertholet V, Boysen C, Bromley B, Brown D, Brunner A, Canales R, Cao XM, Cebula TA, Chen JJ, Cheng J, Chu TM, Chudin E, Corson J, Corton JC, Croner LJ, Davies C, Davison TS, Delenstarr G, Deng X, Dorris D, Eklund AC, Fan XH, Fang H, Fulmer-Smentek S, Fuscoe JC, Gallagher K, Ge W, Guo L, Guo X, Hager J, Haje PK, Han J, Han T, Harbottle HC, Harris SC, Hatchwell E, Hauser CA, Hester S, Hong H, Hurban P, Jackson SA, Ji H, Knight CR, Kuo WP, LeClerc JE, Levy S, Li QZ, Liu C, Liu Y, Lombardi MJ, Ma Y, Magnuson SR, Maqsodi B, McDaniel T, Mei N, Myklebost O, Ning B, Novoradovskaya N, Orr MS, Osborn TW, Papallo A, Patterson TA, Perkins RG, Peters EH, Peterson R, Philips KL, Pine PS, Pusztai L, Qian F, Ren H, Rosen M, Rosenzweig BA, Samaha RR, Schena M, Schroth GP, Shchegrova S, Smith DD, Staedtler F, Su Z, Sun H, Szallasi Z, Tezak Z, Thierry-Mieg D, Thompson KL, Tikhonova I, Turpaz Y, Vallanat B, Van C, Walker SJ, Wang SJ, Wang Y, Wolfinger R, Wong A, Wu J, Xiao C, Xie Q, Xu J, Yang W, Zhang L, Zhong S, Zong Y and Slikker W Jr.: The MicroArray Quality Control (MAQC) project shows interplatform reproducibility of gene expression measurements. Nat Biotechnol 24: 1151-1161, 2006. (Pubitemid 44359727)
10. Nikolsky Y, Ekins S, Nikolskaya T and Bugrim A: A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol Lett 158: 20-29, 2005. (Pubitemid 40910724)
11. Mason CW, Swaan PW, and Weiner CP: Identification of interactive gene networks: A novel approach in gene array profiling of myometrial events during guinea pig pregnancy. Am J Obstet Gynecol 194: 1513-1523, 2006 (Pubitemid 43766889)
12. Guo L, Lobenhofer EK, Wang C, Shippy R, Harris SC, Zhang L, Mei N, Chen T, Herman D, Goodsaid FM, Hurban P, Phillips KL, Xu J, Deng X, Sun YA, Tong W, Dragan YP and Shi L: Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat Biotechnol 24: 1162-1169, 2006. (Pubitemid 44359728)
13. Yang J and Moses MA: Lipocalin 2: A multifaceted modulator of human cancer. Cell Cycle 8: 2347-2352, 2009.
14. Yang J, Bielenberg DR, Rodig SJ, Doiron R, Clifton MC, Kung AL, Strong RK, Zurakowski D and Moses MA: Lipocalin 2 promotes breast cancer progression. Proc Natl Acad Sci USA 106: 3913-3918, 2009.
15. Maass PG, Wirth J, Aydin A, Rump A, Stricker S, Tinschert S, Otero M, Tsuchimochi K, Goldring MB, Luft FC, and Bahring S: A cis-regulatory site downregulates PTHLH in translocation t(8;12)(q13;p11.2) and leads to brachydactyly type E. Hum Mol Genet 19: 848-860, 2010.
16. Loftus SK, Larson DM, Baxter LL, Antonellis A, Chen Y, Wu X, Jiang Y, Bittner M, Hammer JA, and Pavan WJ: Mutation of melanosome protein RAB38 in chocolate mice. Proc Natl Acad Sci USA 99: 4471-4476, 2002. (Pubitemid 34286009)
17. Osanai K, Oikawa R, Higuchi J, Kobayashi M, Tsuchihara K, Iguchi M, Jongsu H, Toga H, and Voelker DR: A mutation in Rab38 small GTPase causes abnormal lung surfactant homeostasis and aberrant alveolar structure in mice. Am J Pathol 173: 1265-1274, 2008.
18. Shedden K, Taylor JM, Enkemann SA, Tsao MS, Yeatman TJ, Gerald WL, Eschrich S, Jurisica I, Giordano TJ, Misek DE, Chang AC, Zhu CQ, Strumpf D, Hanash S, Shepherd FA, Ding K, Seymour L, Naoki K, Pennell N, Weir B, Verhaak R, Ladd-Acosta C, Golub T, Gruidl M, Sharma A, Szoke J, Zakowski M, Rusch V, Kris M, Viale A, Motoi N, Travis W, Conley B, Seshan VE, Meyerson M, Kuick R, Dobbin KK, Lively T, Jacobson JW and Beer DG: Gene expression-based survival prediction in lung adenocarcinoma: a multisite, blinded validation study. Nat Med 14: 822-827, 2008.